ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CLPT vs ANIK // FORWARD P/E MULTIPLE

ClearPoint Neuro Inc. (NASDAQ) VS. Anika Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CLPT 3 — ANIK 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLPT VS. ANIK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CLPT ANIK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 61.40% 56.60% +4.80 CLPT /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -10.20% -24.80 ANIK /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -7.13% 1.50% -8.63 ANIK /fcf-yield <GO>
Operating Margin -60.00% -9.80% -50.20 ANIK /operating-margins <GO>
Net Profit Margin -60.00% -9.80% -50.20 ANIK /net-margins <GO>
Revenue Growth (YoY) 17.80% -5.90% +23.70 CLPT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 6/9 -2.00 ANIK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.1 60.4 -11.30 ANIK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $342.7M $291.6M $51.0M CLPT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CLPT REV ANIK REV CLPT GROSS % ANIK GROSS % CLPT FCF ANIK FCF
FY 2025 $37.0M $112.8M 61.4% 56.6% -$24.4M $4.4M
FY 2024 $31.4M $119.9M 60.9% 63.4% -$9.2M -$2.3M
FY 2023 $24.0M $120.8M — — -$13.7M -$1.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLPT // BETA —
ANIK // BETA —